Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: A phase II study

Lord, R, Nair, S, Schache, A, Spicer, J, Somaihah, N, Khoo, V and Pandha, H (2007) Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: A phase II study JOURNAL OF UROLOGY, 177 (6). 2136 - 2140. ISSN 0022-5347

Preview

PDF 131106_oral_cycloj_urol4.pdf - Accepted Version Download (103Kb)

Item Type:	Article
Additional Information:	NOTICE: this is the author’s version of a work that was accepted for publication in Journal of Urology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Journal of Urology, 177(6), June 2007, DOI 10.1016/j.juro.2007.01.143.
Uncontrolled Keywords:	Science & Technology, Life Sciences & Biomedicine, Urology & Nephrology, cyclophosphamide, prostatic neoplasms, TUMOR-GROWTH, ANGIOGENESIS, CHEMOTHERAPY, MICE
Related URLs:	Author
Divisions:	Faculty of Health and Medical Sciences > Microbial and Cellular Sciences
Depositing User:	Symplectic Elements
Date Deposited:	02 Mar 2012 11:57
Last Modified:	23 Sep 2013 19:14
URI:	http://epubs.surrey.ac.uk/id/eprint/227159

Actions (login required)

View Item

Downloads